Cargando…
_version_ 1783630285015875584
author Pérez-Nadales, Elena
Alastruey-Izquierdo, Ana
Linares-Sicilia, María José
Soto-Debrán, Juan Carlos
Abdala, Edson
García-Rodríguez, Julio
Montejo, Miguel
Muñoz, Patricia
Lletí, Miguel Salavert
Rezusta, Antonio
de Pipaón, Maite Ruiz Pérez
Yáñez, Lucrecia
Merino, Esperanza
Campos-Herrero, María Isolina
Costa-Mateo, José María
Fortún, Jesús
García-Lozano, Tomás
Garcia-Vidal, Carolina
Fernández-Ruiz, Mario
Sánchez-Reus, Ferrán
Castro-Méndez, Carmen
Guerrero-Lozano, Inmaculada
Soler-Palacín, Pere
Aguado, José María
Martínez-Martínez, Luis
Torre-Cisneros, Julian
Nucci, Marcio
author_facet Pérez-Nadales, Elena
Alastruey-Izquierdo, Ana
Linares-Sicilia, María José
Soto-Debrán, Juan Carlos
Abdala, Edson
García-Rodríguez, Julio
Montejo, Miguel
Muñoz, Patricia
Lletí, Miguel Salavert
Rezusta, Antonio
de Pipaón, Maite Ruiz Pérez
Yáñez, Lucrecia
Merino, Esperanza
Campos-Herrero, María Isolina
Costa-Mateo, José María
Fortún, Jesús
García-Lozano, Tomás
Garcia-Vidal, Carolina
Fernández-Ruiz, Mario
Sánchez-Reus, Ferrán
Castro-Méndez, Carmen
Guerrero-Lozano, Inmaculada
Soler-Palacín, Pere
Aguado, José María
Martínez-Martínez, Luis
Torre-Cisneros, Julian
Nucci, Marcio
author_sort Pérez-Nadales, Elena
collection PubMed
description Invasive fusariosis (IF) is associated with severe neutropenia in patients with concurrent hematologic conditions. We conducted a retrospective observational study to characterize the epidemiology of IF in 18 Spanish hospitals during 2000–2015. In that time, the frequency of IF in nonneutropenic patients increased from 0.08 cases per 100,000 admissions in 2000–2009 to 0.22 cases per 100,000 admissions in 2010–2015. Nonneutropenic IF patients often had nonhematologic conditions, such as chronic cardiac or lung disease, rheumatoid arthritis, history of solid organ transplantation, or localized fusariosis. The 90-day death rate among nonneutropenic patients (28.6%) and patients with resolved neutropenia (38.1%) was similar. However, the death rate among patients with persistent neutropenia (91.3%) was significantly higher. We used a multivariate Cox regression analysis to characterize risk factors for death: persistent neutropenia was the only risk factor for death, regardless of antifungal therapy.
format Online
Article
Text
id pubmed-7774531
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-77745312021-01-01 Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000–2015 Pérez-Nadales, Elena Alastruey-Izquierdo, Ana Linares-Sicilia, María José Soto-Debrán, Juan Carlos Abdala, Edson García-Rodríguez, Julio Montejo, Miguel Muñoz, Patricia Lletí, Miguel Salavert Rezusta, Antonio de Pipaón, Maite Ruiz Pérez Yáñez, Lucrecia Merino, Esperanza Campos-Herrero, María Isolina Costa-Mateo, José María Fortún, Jesús García-Lozano, Tomás Garcia-Vidal, Carolina Fernández-Ruiz, Mario Sánchez-Reus, Ferrán Castro-Méndez, Carmen Guerrero-Lozano, Inmaculada Soler-Palacín, Pere Aguado, José María Martínez-Martínez, Luis Torre-Cisneros, Julian Nucci, Marcio Emerg Infect Dis Synopsis Invasive fusariosis (IF) is associated with severe neutropenia in patients with concurrent hematologic conditions. We conducted a retrospective observational study to characterize the epidemiology of IF in 18 Spanish hospitals during 2000–2015. In that time, the frequency of IF in nonneutropenic patients increased from 0.08 cases per 100,000 admissions in 2000–2009 to 0.22 cases per 100,000 admissions in 2010–2015. Nonneutropenic IF patients often had nonhematologic conditions, such as chronic cardiac or lung disease, rheumatoid arthritis, history of solid organ transplantation, or localized fusariosis. The 90-day death rate among nonneutropenic patients (28.6%) and patients with resolved neutropenia (38.1%) was similar. However, the death rate among patients with persistent neutropenia (91.3%) was significantly higher. We used a multivariate Cox regression analysis to characterize risk factors for death: persistent neutropenia was the only risk factor for death, regardless of antifungal therapy. Centers for Disease Control and Prevention 2021-01 /pmc/articles/PMC7774531/ /pubmed/33352085 http://dx.doi.org/10.3201/eid2701.190782 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Synopsis
Pérez-Nadales, Elena
Alastruey-Izquierdo, Ana
Linares-Sicilia, María José
Soto-Debrán, Juan Carlos
Abdala, Edson
García-Rodríguez, Julio
Montejo, Miguel
Muñoz, Patricia
Lletí, Miguel Salavert
Rezusta, Antonio
de Pipaón, Maite Ruiz Pérez
Yáñez, Lucrecia
Merino, Esperanza
Campos-Herrero, María Isolina
Costa-Mateo, José María
Fortún, Jesús
García-Lozano, Tomás
Garcia-Vidal, Carolina
Fernández-Ruiz, Mario
Sánchez-Reus, Ferrán
Castro-Méndez, Carmen
Guerrero-Lozano, Inmaculada
Soler-Palacín, Pere
Aguado, José María
Martínez-Martínez, Luis
Torre-Cisneros, Julian
Nucci, Marcio
Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000–2015
title Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000–2015
title_full Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000–2015
title_fullStr Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000–2015
title_full_unstemmed Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000–2015
title_short Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000–2015
title_sort invasive fusariosis in nonneutropenic patients, spain, 2000–2015
topic Synopsis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774531/
https://www.ncbi.nlm.nih.gov/pubmed/33352085
http://dx.doi.org/10.3201/eid2701.190782
work_keys_str_mv AT pereznadaleselena invasivefusariosisinnonneutropenicpatientsspain20002015
AT alastrueyizquierdoana invasivefusariosisinnonneutropenicpatientsspain20002015
AT linaressiciliamariajose invasivefusariosisinnonneutropenicpatientsspain20002015
AT sotodebranjuancarlos invasivefusariosisinnonneutropenicpatientsspain20002015
AT abdalaedson invasivefusariosisinnonneutropenicpatientsspain20002015
AT garciarodriguezjulio invasivefusariosisinnonneutropenicpatientsspain20002015
AT montejomiguel invasivefusariosisinnonneutropenicpatientsspain20002015
AT munozpatricia invasivefusariosisinnonneutropenicpatientsspain20002015
AT lletimiguelsalavert invasivefusariosisinnonneutropenicpatientsspain20002015
AT rezustaantonio invasivefusariosisinnonneutropenicpatientsspain20002015
AT depipaonmaiteruizperez invasivefusariosisinnonneutropenicpatientsspain20002015
AT yanezlucrecia invasivefusariosisinnonneutropenicpatientsspain20002015
AT merinoesperanza invasivefusariosisinnonneutropenicpatientsspain20002015
AT camposherreromariaisolina invasivefusariosisinnonneutropenicpatientsspain20002015
AT costamateojosemaria invasivefusariosisinnonneutropenicpatientsspain20002015
AT fortunjesus invasivefusariosisinnonneutropenicpatientsspain20002015
AT garcialozanotomas invasivefusariosisinnonneutropenicpatientsspain20002015
AT garciavidalcarolina invasivefusariosisinnonneutropenicpatientsspain20002015
AT fernandezruizmario invasivefusariosisinnonneutropenicpatientsspain20002015
AT sanchezreusferran invasivefusariosisinnonneutropenicpatientsspain20002015
AT castromendezcarmen invasivefusariosisinnonneutropenicpatientsspain20002015
AT guerrerolozanoinmaculada invasivefusariosisinnonneutropenicpatientsspain20002015
AT solerpalacinpere invasivefusariosisinnonneutropenicpatientsspain20002015
AT aguadojosemaria invasivefusariosisinnonneutropenicpatientsspain20002015
AT martinezmartinezluis invasivefusariosisinnonneutropenicpatientsspain20002015
AT torrecisnerosjulian invasivefusariosisinnonneutropenicpatientsspain20002015
AT nuccimarcio invasivefusariosisinnonneutropenicpatientsspain20002015
AT invasivefusariosisinnonneutropenicpatientsspain20002015